CoreRX Inc.February 26, 2026

FDA 483 - CoreRX Inc. - February 26, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore CoreRX Inc.

Record Details

CoreRX Inc. DBA Bend Bioscience, a contract drug manufacturer in Clearwater, FL, was inspected and cited for seven observations. The inspection revealed significant deficiencies in production and process controls, component testing, environmental monitoring, facility maintenance, and computer system controls. These issues indicate a lack of adequate procedures and scientific justification to ensure drug product quality and integrity.

Company: CoreRX Inc.
Inspection Date: February 26, 2026
Product Type: Drugs
Office: Florida District Office
People: Kayla V. Sprague (Pharmaceutical Investigator)
Nicole E. Knowlton (Investigator )
Tammy T. Brown (investigator)

Open in Dashboard

ID · f623fd94-2144-4fc8-860e-edd827c6ad95